These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8662705)

  • 1. Mapping of the discontinuous kininogen binding site of prekallikrein. A distal binding segment is located in the heavy chain domain A4.
    Herwald H; Renné T; Meijers JC; Chung DW; Page JD; Colman RW; Müller-Esterl W
    J Biol Chem; 1996 May; 271(22):13061-7. PubMed ID: 8662705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of the high molecular weight kininogen binding site of prekallikrein. Evidence for a discontinuous epitope formed by distinct segments of the prekallikrein heavy chain.
    Herwald H; Jahnen-Dechent W; Alla SA; Hock J; Bouma BN; Müller-Esterl W
    J Biol Chem; 1993 Jul; 268(19):14527-35. PubMed ID: 7686159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of the discontinuous H-kininogen binding site of plasma prekallikrein. Evidence for a critical role of apple domain-2.
    Renné T; Dedio J; Meijers JC; Chung D; Müller-Esterl W
    J Biol Chem; 1999 Sep; 274(36):25777-84. PubMed ID: 10464316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine mapping of the H-kininogen binding site in plasma prekallikrein apple domain 2.
    Renné T; Sugiyama A; Gailani D; Jahnen-Dechent W; Walter U; Müller-Esterl W
    Int Immunopharmacol; 2002 Dec; 2(13-14):1867-73. PubMed ID: 12489801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371).
    Page JD; Colman RW
    J Biol Chem; 1991 May; 266(13):8143-8. PubMed ID: 1708772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High molecular weight kininogen-binding site of prekallikrein probed by monoclonal antibodies.
    Hock J; Vogel R; Linke RP; Müller-Esterl W
    J Biol Chem; 1990 Jul; 265(20):12005-11. PubMed ID: 1694851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of the prekallikrein-binding site of human H-kininogen by ligand screening of lambda gt11 expression libraries. Mimicking of the predicted binding site by anti-idiotypic antibodies.
    Vogel R; Kaufmann J; Chung DW; Kellermann J; Müller-Esterl W
    J Biol Chem; 1990 Jul; 265(21):12494-502. PubMed ID: 1695630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain.
    Page JD; You JL; Harris RB; Colman RW
    Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface.
    Veloso D; Silver LD; Hahn S; Colman RW
    Blood; 1987 Oct; 70(4):1053-62. PubMed ID: 2443201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of the H-kininogen binding site exposed by the prekallikrein heavy chain.
    Herwald H; Hock H; Jahnen-Dechent W; Müller-Esterl W
    Agents Actions Suppl; 1992; 38 ( Pt 1)():225-32. PubMed ID: 1466274
    [No Abstract]   [Full Text] [Related]  

  • 11. The shape of high molecular weight kininogen. Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy.
    Weisel JW; Nagaswami C; Woodhead JL; DeLa Cadena RA; Page JD; Colman RW
    J Biol Chem; 1994 Apr; 269(13):10100-6. PubMed ID: 8144509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor.
    Herwald H; Dedio J; Kellner R; Loos M; Müller-Esterl W
    J Biol Chem; 1996 May; 271(22):13040-7. PubMed ID: 8662673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity.
    Reddigari SR; Kaplan AP
    Blood; 1989 Aug; 74(2):695-702. PubMed ID: 2752143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains.
    Bock PE; Shore JD; Tans G; Griffin JH
    J Biol Chem; 1985 Oct; 260(23):12434-43. PubMed ID: 3850090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel mechanisms of high molecular weight kininogen action as a cofactor in kallikrein inactivation and prekallikrein activation reactions.
    Olson ST; Francis AM; Sheffer R; Choay J
    Biochemistry; 1993 Nov; 32(45):12148-59. PubMed ID: 8218292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein.
    Renné T; Gailani D; Meijers JC; Müller-Esterl W
    J Biol Chem; 2002 Feb; 277(7):4892-9. PubMed ID: 11733491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational analysis of synthetic peptides encompassing the factor XI and prekallikrein overlapping binding domains of high molecular weight kininogen.
    You JL; Page JD; Scarsdale JN; Colman RW; Harris RB
    Peptides; 1993; 14(5):867-76. PubMed ID: 8284263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikrein.
    Kerbiriou DM; Bouma BN; Griffin JH
    J Biol Chem; 1980 May; 255(9):3952-8. PubMed ID: 6154706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an endothelial cell binding site on kininogen domain D3.
    Herwald H; Hasan AA; Godovac-Zimmermann J; Schmaier AH; Müller-Esterl W
    J Biol Chem; 1995 Jun; 270(24):14634-42. PubMed ID: 7540175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the binding site for plasma prekallikrein in human high molecular weight kininogen. A region from residues 185 to 224 of the kininogen light chain retains full binding activity.
    Tait JF; Fujikawa K
    J Biol Chem; 1986 Nov; 261(33):15396-401. PubMed ID: 3096985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.